BUY Reliance Industries — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))10 Jun 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·9 Jun · 6d ago
Moody's upgraded Reliance Industries Ltd's rating for Senior Unsecured Notes from Baa2 to Baa1 with a Stable outlook.
BSE · Company Update·29 May · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Reliance Industries
- BUY — Vikas Sethi, Sethi Finmart22 Oct 2026 · Same day · target ₹1,225 · SL hit
- BUY — Morgan Stanley22 Oct 2026 · ~1 year · target ₹1,525 · Active
- BUY — Rajesh Satpute21 Oct 2026 · Next day · target ₹1,245 · Expired
- BUY — Kunal Bothra21 Oct 2026 · Same day · target ₹1,250 · Expired
- BUY — Citigroup21 Oct 2026 · ~1 year · target ₹1,300 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

